The privacy-versus-convenience trade-off lands differently when the discomfort is coming from excess weight and metabolic problems - the cost of the data point feels abstract compared to the cost of not using what works. The disclosure question on a forum like this is a separate calculation...
Semaglutide dosing is completely different from supplements - 0.25mg starting is a GI tolerance step, not therapeutic. The escalation to 1mg is where the real effect begins.
Harbor tracks consistently on Reta - quality and response time both solid. Protein-and-fiber high is the right frame; cutting calories too hard on GLP-1s triggers the muscle-loss pattern that stalls the back half.
Just FYI, in the clinical trials, people took 0.25mg for a month, then 0.5mg for a month, 1.0mg for a month, 1.7mg for a month, and then finally stayed at 2.4mg.
Isn't that some chemical thing, like a blueprint for making it? Maybe the configuration makes it harder to create? I think Cys is 'cystein', an amino acid?? I'm no chemist, though ;-)
Why not give the cagri a shot first? I'm loving it at 0.25mg. Isn't eloralintide still super early in development? I'm curious why you're so set on that one.
It's been a month and a half! I've dropped 23, maybe 24 pounds. This is a total game changer. I'm planning to stay at the lowest dose, .5, because I'm paying for this myself.